Butalbital Compound (Major Pharmaceuticals)
Welcome to the PulseAid listing for the Butalbital Compound drug offered from Major Pharmaceuticals. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Major Pharmaceuticals |
NON-PROPRIETARY NAME: | Bultabital, Aspirin and Caffeine |
SUBSTANCE NAME: | ASPIRIN; BUTALBITAL; CAFFEINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Barbiturate [EPC],Barbiturates [Chemical/Ingredient],Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2000-01-28 |
END MARKETING DATE: | 0000-00-00 |
Butalbital Compound HUMAN PRESCRIPTION DRUG Details:
Item Description | Butalbital Compound from Major Pharmaceuticals |
LABELER NAME: | Major Pharmaceuticals |
DEA SCHEDULE: | CIII
|
ACTIVE STRENGTH: | 325; 50; 40(mg/1; mg/1; mg/1) |
START MARKETING DATE: | 2000-01-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0904-3892_86094c4b-064b-475b-b37a-be2fdba03f50 |
PRODUCT NDC: | 0904-3892 |
APPLICATION NUMBER: | ANDA086162 |
Other ASPIRIN; BUTALBITAL; CAFFEINE Pharmaceutical Manufacturers / Labelers: